ABSTRACT
Fact Sheet for Healthcare Providers: Emory Medical Laboratories SARS-CoV-2 RBD IgG Test [open pdf - 83KB]
From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] RBD [receptor-binding domain] IgG [immunoglobulin G] test. The SARS-CoV-2 RBD IgG test is authorized for the detection of IgG antibodies to SARS-CoV-2 in human serum."
| Publisher: | |
| Date: | 2020-06-15 |
| Series: | |
| Copyright: | Public Domain |
| Retrieved From: | U.S. Food and Drug Administration: https://www.fda.gov/ |
| Format: | pdf |
| Media Type: | application/pdf |
| URL: |